Citation Impact
Citing Papers
Ferroptosis: molecular mechanisms and health implications
2020 Standout
Oxyl radicals, redox-sensitive signalling cascades and antioxidants
2007 Standout
Hypoxia-Inducible Factor Activation Protects the Kidney from Gentamicin-Induced Acute Injury
2012
Natural and synthetic inhibitors of kallikrein-related peptidases (KLKs)
2010
Aberrant human tissue kallikrein levels in the stratum corneum and serum of patients with psoriasis: dependence on phenotype, severity and therapy
2007
Calcineurin Inhibitor Nephrotoxicity
2009 Standout
Mechanisms of hypoxia signalling: new implications for nephrology
2019 StandoutNobel
ROS in cancer therapy: the bright side of the moon
2020 Standout
Innate immunity in diabetic kidney disease
2020
Cardiac function and remodeling is attenuated in transgenic rats expressing the human kallikrein-1 gene after myocardial infarction
2006
Renal cell apoptosis induced by nephrotoxic drugs: cellular and molecular mechanisms and potential approaches to modulation
2007
The extracellular matrix protein fibronectin is a substrate for kallikrein 7
2008
TGF-β: the master regulator of fibrosis
2016 Standout
Hallmarks of aging: An expanding universe
2023 Standout
NADPH Oxidase Activity Selectively Modulates Vascular Endothelial Growth Factor Signaling Pathways
2007
The molecular machinery of regulated cell death
2019 Standout
Resveratrol Improves Survival, Hemodynamics and Energetics in a Rat Model of Hypertension Leading to Heart Failure
2011
Acute kidney injury
2019 Standout
Tissue Kallikrein Inhibitors Based on the Sunflower Trypsin Inhibitor Scaffold – A Potential Therapeutic Intervention for Skin Diseases
2016 StandoutNobel
Noncoding RNAs in age-related cardiovascular diseases
2022
HMGB1 in health and disease
2014
Management of Chronic Kidney Disease Patients in the Intensive Care Unit: Mixing Acute and Chronic Illness
2017 Standout
Role of bone morphogenetic protein-7 in renal fibrosis
2015
Type 2 diabetes mellitus
2015 Standout
Differential effects of salt on renal hemodynamics and potential pressure transmission in stroke-prone and stroke-resistant spontaneously hypertensive rats
2005
Inflammation in obesity, diabetes, and related disorders
2022 Standout
Downregulation of TIMP2 attenuates sepsis-induced AKI through the NF-κb pathway
2018
Oxidant Stress in Renal Pathophysiology
2005
Dietary (Poly)phenolics in Human Health: Structures, Bioavailability, and Evidence of Protective Effects Against Chronic Diseases
2012 Standout
The Kallikrein-Kinin System in Diabetic Retinopathy
2014
Amyloid β peptide cleavage by kallikrein 7 attenuates fibril growth and rescues neurons from Aβ-mediated toxicity in vitro
2013 StandoutNobel
Gingerol Fraction from Zingiber officinale Protects against Gentamicin-Induced Nephrotoxicity
2014
Bradykinin B1 and B2 receptors both have protective roles in renal ischemia/reperfusion injury
2007 StandoutNobel
Bioactive Compounds and Bioactivities of Ginger (Zingiber officinale Roscoe)
2019 Standout
Works of Grant Bledsoe being referenced
Role of Tissue Kallikrein in Prevention and Recovery of Gentamicin-Induced Renal Injury
2008
Kallikrein/kinin protects against gentamicin-induced nephrotoxicity by inhibition of inflammation and apoptosis
2006
Tissue kallikrein in cardiovascular, cerebrovascular and renal diseases and skin wound healing
2010
The tissue kallikrein-kinin system protects against cardiovascular and renal diseases and ischemic stroke independently of blood pressure reduction
2006
Tissue kallikrein attenuates salt-induced renal fibrosis by inhibition of oxidative stress
2004
Identification of a Major Heparin-binding Site in Kallistatin
2001
Reversal of Renal Fibrosis, Inflammation, and Glomerular Hypertrophy by Kallikrein Gene Delivery
2006
Reversal of Renal Fibrosis, Inflammation, and Glomerular Hypertrophy by Kallikrein Gene Delivery
2006
Depletion of endogenous kallistatin exacerbates renal and cardiovascular oxidative stress, inflammation, and organ remodeling
2012
Kinin Infusion Prevents Renal Inflammation, Apoptosis, and Fibrosis via Inhibition of Oxidative Stress and Mitogen-Activated Protein Kinase Activity
2007
Human kallistatin administration reduces organ injury and improves survival in a mouse model of polymicrobial sepsis
2014
Blockade of endogenous tissue kallikrein aggravates renal injury by enhancing oxidative stress and inhibiting matrix degradation
2010
Kallistatin reduces vascular senescence and aging by regulating microRNA ‐34a‐SIRT 1 pathway
2017
Kallikrein gene delivery attenuates cardiac remodeling and promotes neovascularization in spontaneously hypertensive rats
2003